Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism

NCT03226171 is registered in ClinicalTrials.gov with Sanwa Kagaku Kenkyusho Co., Ltd. as lead sponsor.

NCT NCT03226171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism
Lead sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
June 20, 2017
Completion date
September 11, 2018
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism